Startseite>>Signaling Pathways>> Tyrosine Kinase>> PDGFR>>Vorolanib

Vorolanib (Synonyms: CM082; X-82)

Katalog-Nr.GC38380

Vorolanib (CM082) ist ein oral aktiver, potenter Multikinase-VEGFR/PDGFR-Hemmer.

Products are for research use only. Not for human use. We do not sell to patients.

Vorolanib Chemische Struktur

Cas No.: 1013920-15-4

Größe Preis Lagerbestand Menge
5mg
125,00 $
Auf Lager
10mg
205,00 $
Auf Lager
50mg
598,00 $
Auf Lager
100mg
846,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Vorolanib (CM082; X-82) is an orally active, multikinase VEGFR/PDGFR inhibitor. Vorolanib minimizes toxicity, disrupts tumor angiogenesis and tumor cell proliferation, and induces of tumor cell death[1].

[1]. Bendell JC, et al. Phase I, First-in-Human, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Vorolanib in Patients with Advanced Solid Tumors. Oncologist. 2019 Apr;24(4):455-e121.

Bewertungen

Review for Vorolanib

Average Rating: 5 ★★★★★ (Based on Reviews and 36 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Vorolanib

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.